Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Dare Bioscience stock
Learn how to easily invest in Dare Bioscience stock.
Dare Bioscience is a biotechnology business based in the US. Dare Bioscience shares (DARE) are listed on the NASDAQ and all prices are listed in US Dollars. Dare Bioscience employs 20 staff and has a trailing 12-month revenue of around $10 million.
How to buy Dare Bioscience stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – DARE. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Trade stocks and ETFs for $0 and no annual fee
- Minimum deposit of $10 required
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
Dare Bioscience stock price (NASDAQ: DARE)Use our graph to track the performance of DARE stocks over time.
Dare Bioscience shares at a glance
|Latest market close||$1.24|
|52-week range||$0.82 - $1.88|
|50-day moving average||$0.97|
|200-day moving average||$1.10|
|Wall St. target price||$5.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.56|
Buy Dare Bioscience stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Dare Bioscience stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Dare Bioscience price performance over time
|1 week (2023-01-26)||-8.82%|
|1 month (2022-12-30)||49.40%|
|3 months (2022-11-02)||22.77%|
|6 months (2022-08-02)||6.90%|
|1 year (2022-02-01)||-22.01%|
|2 years (2021-02-02)||-41.09%|
|3 years (2020-01-31)||10.70%|
|5 years (2018-02-02)||2.175|
Dare Bioscience financials
|Revenue TTM||$10 million|
|Gross profit TTM||$-100,000|
|Return on assets TTM||-31.13%|
|Return on equity TTM||-84.31%|
|Market capitalisation||$115.4 million|
TTM: trailing 12 months
Dare Bioscience share dividends
We're not expecting Dare Bioscience to pay a dividend over the next 12 months.
Have Dare Bioscience's shares ever split?
Dare Bioscience's shares were split on a 1:10 basis on 19 July 2017. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Dare Bioscience shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Dare Bioscience shares which in turn could have impacted Dare Bioscience's share price.
Dare Bioscience share price volatility
Over the last 12 months, Dare Bioscience's shares have ranged in value from as little as $0.82 up to $1.88. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Dare Bioscience's is 1.1904. This would suggest that Dare Bioscience's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Dare Bioscience overview
Daré Bioscience, Inc. , a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in female patients 12 years of age and older. Its products in advanced clinical development include Ovaprene, a hormone-free monthly vaginal contraceptive; and Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder. The company's Phase 1-ready products are DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for the treatment of vasomotor symptoms in hormone therapy; DARE-VVA1, a vaginally delivered formulation of tamoxifen to treat vulvar and vaginal atrophy in patients with hormone-receptor positive breast cancer; and DARE-FRT1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth and broader luteal phase support as part of an in vitro fertilization treatment plan, as well as DARE-PTB1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth. Its products in pre-clinical stage include DARE-LARC1, a combination product designed to provide reversible contraception; ADARE-204 and ADARE-214, an injectable formulations of etonogestrel to provide contraception over 6-month and 12-month periods; and DARE-RH1, a non-hormonal contraception for men and women.
Dare Bioscience in the news
Daré Bioscience to Participate in Three February Conferences
Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1 Trial of DARE-HRT1 that Support the Potential of DARE-HRT1 as an Effective Hormone Therapy for both Vasomotor and Vaginal Symptoms of Menopause
Daré Bioscience Announces Positive Pharmacokinetic (PK) Results from the DARE-HRT1 Phase 1 / 2 Study that Support the Potential of DARE-HRT1 as an Effective Hormone Therapy for both Vasomotor and Vaginal Symptoms of Menopause
Frequently asked questionsWhat percentage of Dare Bioscience is owned by insiders or institutions?
Currently 1.96% of Dare Bioscience shares are held by insiders and 9.306% by institutions. How many people work for Dare Bioscience?
Latest data suggests 20 work at Dare Bioscience. When does the fiscal year end for Dare Bioscience?
Dare Bioscience's fiscal year ends in December. Where is Dare Bioscience based?
Dare Bioscience's address is: 3655 Nobel Drive, San Diego, CA, United States, 92122 What is Dare Bioscience's ISIN number?
Dare Bioscience's international securities identification number is: US23666P1012 What is Dare Bioscience's CUSIP number?
Dare Bioscience's Committee on Uniform Securities Identification Procedures number is: 15708Q105
More guides on Finder
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert